HSA Product

STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml

Product approved by Health Sciences Authority (SG)

Basic Information

Product Name

STERI-NEB IPRATROPIUM NEBULISER SOLUTION 250 mcg/ml

Dosage Form

SOLUTION

Regulatory Information

Approval Number

SIN10039P

Approval Date

September 17, 1998

Forensic Classification

Prescription Only

Drug Type

Therapeutic

Route of Administration

NASAL

Record Created

August 10, 2023

Last Updated

June 3, 2025

ATC Business ID

XR03BB01

Company Information

ManufacturerIVAX PHARMACEUTICALS UK

Registrant

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Licence Holder

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Active Ingredients

IPRATROPIUM BROMIDE

Strength: 250 mcg/ml

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy